Clinical efficacy of fecal occult blood test and colonoscopy for dasatinib-induced hemorrhagic colitis in CML patients

被引:16
作者
Nishiwaki, Satoshi [1 ,2 ]
Maeda, Matsuyoshi [3 ]
Yamada, Masahiro [4 ]
Okuno, Shingo [1 ]
Harada, Yasuhiko [1 ]
Suzuki, Kotaro [1 ]
Kurahashi, Shingo [1 ]
Urano, Fumihiro [4 ]
Okamura, Shozo [4 ]
Sugiura, Isamu [1 ]
机构
[1] Toyohashi Municipal Hosp, Div Hematol & Oncol, Toyohashi, Aichi, Japan
[2] Nagoya Univ Hosp, Ctr Adv Med & Clin Res, Nagoya, Aichi, Japan
[3] Toyohashi Municipal Hosp, Div Pathol, Toyohashi, Aichi, Japan
[4] Toyohashi Municipal Hosp, Div Gastroenterol, Toyohashi, Aichi, Japan
关键词
CHRONIC MYELOID-LEUKEMIA; TYROSINE KINASE INHIBITORS; CHRONIC-PHASE; PLEURAL EFFUSION; ADVERSE EVENTS; IMATINIB; MANAGEMENT; RECOMMENDATIONS; CELLS;
D O I
10.1182/blood-2016-08-734947
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:126 / 128
页数:3
相关论文
共 25 条
[1]   European LeukemiaNet recommendations for the management of chronic myeloid leukemia: 2013 [J].
Baccarani, Michele ;
Deininger, Michael W. ;
Rosti, Gianantonio ;
Hochhaus, Andreas ;
Soverini, Simona ;
Apperley, Jane F. ;
Cervantes, Francisco ;
Clark, Richard E. ;
Cortes, Jorge E. ;
Guilhot, Francois ;
Hjorth-Hansen, Henrik ;
Hughes, Timothy P. ;
Kantarjian, Hagop M. ;
Kim, Dong-Wook ;
Larson, Richard A. ;
Lipton, Jeffrey H. ;
Mahon, Francois-Xavier ;
Martinelli, Giovanni ;
Mayer, Jiri ;
Mueller, Martin C. ;
Niederwieser, Dietger ;
Pane, Fabrizio ;
Radich, Jerald P. ;
Rousselot, Philippe ;
Saglio, Giuseppe ;
Saussele, Susanne ;
Schiffer, Charles ;
Silver, Richard ;
Simonsson, Bengt ;
Steegmann, Juan-Luis ;
Goldman, John M. ;
Hehlmann, Ruediger .
BLOOD, 2013, 122 (06) :872-884
[2]   Lung abnormalities after dasatinib treatment for chronic myeloid leukemia -: A case series [J].
Bergeron, Anne ;
Rea, Delphine ;
Levy, Vincent ;
Picard, Clement ;
Meignin, Veronique ;
Tamburini, Jerome ;
Bruzzoni-Giovanelli, Heriberto ;
Calvo, Fabien ;
Tazi, Abdellatif ;
Rousselot, Philippe .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2007, 176 (08) :814-818
[3]   Achieving deeper molecular response is associated with a better clinical outcome in chronic myeloid leukemia patients on imatinib front-line therapy [J].
Etienne, Gabriel ;
Dulucq, Stephanie ;
Nicolini, Franck-Emmanuel ;
Morisset, Stephane ;
Fort, Marie-Pierre ;
Schmitt, Anna ;
Etienne, Madeleine ;
Hayette, Sandrine ;
Lippert, Eric ;
Bureau, Caroline ;
Tigaud, Isabelle ;
Adiko, Didier ;
Marit, Gerald ;
Reiffers, Josy ;
Mahon, Francois-Xavier .
HAEMATOLOGICA, 2014, 99 (03) :458-464
[4]   Drug interactions with the tyrosine kinase inhibitors imatinib, dasatinib, and nilotinib [J].
Haouala, Amina ;
Widmer, Nicolas ;
Duchosal, Michel A. ;
Montemurro, Michael ;
Buclin, Thierry ;
Decosterd, Laurent A. .
BLOOD, 2011, 117 (08) :E75-E87
[5]   Sensitivity of immunochemical faecal occult blood testing for detecting left- vs right-sided colorectal neoplasia [J].
Haug, U. ;
Kuntz, K. M. ;
Knudsen, A. B. ;
Hundt, S. ;
Brenner, H. .
BRITISH JOURNAL OF CANCER, 2011, 104 (11) :1779-1785
[6]  
Jabbour E, 2011, LEUKEMIA, V25, P201, DOI 10.1038/leu.2010.215
[7]   Safety and efficacy of imatinib in CML over a period of 10 years: data from the randomized CML-study IV [J].
Kalmanti, L. ;
Saussele, S. ;
Lauseker, M. ;
Mueller, M. C. ;
Dietz, C. T. ;
Heinrich, L. ;
Hanfstein, B. ;
Proetel, U. ;
Fabarius, A. ;
Krause, S. W. ;
Rinaldetti, S. ;
Dengler, J. ;
Falge, C. ;
Oppliger-Leibundgut, E. ;
Burchert, A. ;
Neubauer, A. ;
Kanz, L. ;
Stegelmann, F. ;
Pfreundschuh, M. ;
Spiekermann, K. ;
Scheid, C. ;
Pfirrmann, M. ;
Hochhaus, A. ;
Hasford, J. ;
Hehlmann, R. .
LEUKEMIA, 2015, 29 (05) :1123-1132
[8]   Dasatinib versus Imatinib in Newly Diagnosed Chronic-Phase Chronic Myeloid Leukemia [J].
Kantarjian, Hagop ;
Shah, Neil P. ;
Hochhaus, Andreas ;
Cortes, Jorge ;
Shah, Sandip ;
Ayala, Manuel ;
Moiraghi, Beatriz ;
Shen, Zhixiang ;
Mayer, Jiri ;
Pasquini, Ricardo ;
Nakamae, Hirohisa ;
Huguet, Francoise ;
Boque, Concepcion ;
Chuah, Charles ;
Bleickardt, Eric ;
Bradley-Garelik, M. Brigid ;
Zhu, Chao ;
Szatrowski, Ted ;
Shapiro, David ;
Baccarani, Michele .
NEW ENGLAND JOURNAL OF MEDICINE, 2010, 362 (24) :2260-2270
[9]   Dasatinib or imatinib in newly diagnosed chronic-phase chronic myeloid leukemia: 2-year follow-up from a randomized phase 3 trial (DASISION) [J].
Kantarjian, Hagop M. ;
Shah, Neil P. ;
Cortes, Jorge E. ;
Baccarani, Michele ;
Agarwal, Mohan B. ;
Soledad Undurraga, Maria ;
Wang, Jianxiang ;
Kassack Ipina, Juan Julio ;
Kim, Dong-Wook ;
Ogura, Michinori ;
Pavlovsky, Carolina ;
Junghanss, Christian ;
Milone, Jorge H. ;
Nicolini, Franck E. ;
Robak, Tadeusz ;
Van Droogenbroeck, Jan ;
Vellenga, Edo ;
Bradley-Garelik, M. Brigid ;
Zhu, Chao ;
Hochhaus, Andreas .
BLOOD, 2012, 119 (05) :1123-1129
[10]  
Kmira Zahra, 2013, World J Gastrointest Pathophysiol, V4, P59, DOI 10.4291/wjgp.v4.i3.59